Nurse-led efforts to provide patients with ongoing lifestyle advice, education, and other resources reduced MACE by 30%.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

LV thrombus is less of an issue now thanks to primary PCI and antithrombotics, but it still occurs in 9% of anterior MIs.

Mamas Mamas, Stefan Anker, and Volker Rudolph talk about their studies of MitraClip for functional MR in patients with heart ...

Liberal fluid intake was safe and suggestive of better health status: this should be enough to stop restricting patients to 1 ...

Additional research is needed to determine whether this is due to direct drug effects or underlying patient factors.

Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.

Cotemporary DES paired with FFR guidance and modern medical therapy may be what narrowed the gap, William Fearon says.

Experts are dismayed, disappointed, and confused, but many say this isn’t the end of cerebral embolic protection for TAVI.

The prothrombin complex concentrate costs more than plasma, but may pay dividends by way of fewer adverse events.

The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.

Mamas Mamas, Eileen Handberg, and C. Noel Bairey Merz discuss how the recent WARRIOR trial results can help inform treatment ...